Skip Nav Destination
Issues
1 January 2011
-
Cover Image
Cover Image
![issue cover]()
Double immunofluorescence for nestin (pink) and the endothelial marker CD34 (green) with EGFR fluorescence in situ hybridization (red) confirms expression of nestin in endothelial cells and in GBM cells of patients treated with cediranib. For details, see the article by di Tomaso et al. on page 19 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Issue Sections
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Priority Report
Clinical Studies
Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of “Rebound” Revascularization as Mode of Escape
Emmanuelle di Tomaso; Matija Snuderl; Walid S. Kamoun; Dan G. Duda; Pavan K. Auluck; Ladan Fazlollahi; Ovidiu C. Andronesi; Matthew P. Frosch; Patrick Y. Wen; Scott R. Plotkin; E. Tessa Hedley-Whyte; A. Gregory Sorensen; Tracy T. Batchelor; Rakesh K. Jain
Integrated Systems and Technologies
Genetic and Structural Variation in the Gastric Cancer Kinome Revealed through Targeted Deep Sequencing
Zhi Jiang Zang; Choon Kiat Ong; Ioana Cutcutache; Willie Yu; Shen Li Zhang; Dachuan Huang; Lian Dee Ler; Karl Dykema; Anna Gan; Jiong Tao; Siyu Lim; Yujing Liu; P. Andrew Futreal; Heike Grabsch; Kyle A. Furge; Liang Kee Goh; Steve Rozen; Bin Tean Teh; Patrick Tan
Microenvironment and Immunology
Molecular and Cellular Pathobiology
Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy
Tommy Martinsson; Therese Eriksson; Jonas Abrahamsson; Helena Caren; Magnus Hansson; Per Kogner; Sattu Kamaraj; Christina Schönherr; Joel Weinmar; Kristina Ruuth; Ruth H. Palmer; Bengt Hallberg
Dose-Dependent Effects of Focal Fractionated Irradiation on Secondary Malignant Neoplasms in Nf1 Mutant Mice
Jean L. Nakamura; Connie Phong; Emile Pinarbasi; Scott C. Kogan; Scott Vandenberg; Andrew E. Horvai; Bruce A. Faddegon; Dorothea Fiedler; Kevan Shokat; Benjamin T. Houseman; Richard Chao; Russell O. Pieper; Kevin Shannon
Prevention and Epidemiology
Therapeutics, Targets, and Chemical Biology
VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
Wouter B. Nagengast; Marjolijn N. Lub-de Hooge; Sjoukje F. Oosting; Wilfred F.A. den Dunnen; Frank-Jan Warnders; Adrienne H. Brouwers; Johan R. de Jong; Patricia M. Price; Harry Hollema; Geke A.P. Hospers; Philip H. Elsinga; Jan Willem Hesselink; Jourik A. Gietema; Elisabeth G.E. de Vries
Autophagic Survival in Resistance to Histone Deacetylase Inhibitors: Novel Strategies to Treat Malignant Peripheral Nerve Sheath Tumors
Gonzalo Lopez; Keila Torres; Juehui Liu; Belinda Hernandez; Eric Young; Roman Belousov; Svetlana Bolshakov; Alexander J. Lazar; John M. Slopis; Ian E. McCutcheon; David McConkey; Dina Lev
Tumor and Stem Cell Biology
Letter to the Editor
Corrections
Advertisement
